The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
Status:
COMPLETED
Trial end date:
2024-08-09
Target enrollment:
Participant gender:
Summary
A Phase 1, Open-Label, Prospective, Dose-finding Clinical Trial for Evaluation of Safety and Tolerability of Intramuscular Injections of CLZ-2002 for the Treatment of Subjects with Charcot-Marie-Tooth type 1(CMT 1)